 Trans-Activators
"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
| Descriptor ID |
D015534
|
| MeSH Number(s) |
D12.776.260.755 D12.776.930.900 D12.776.964.925.984
|
| Concept/Terms |
Trans-Activators- Trans-Activators
- Trans Activators
- Transactivators
- Trans-Activator
- Trans Activator
- Transactivator
- Trans-Acting Factor
- Factor, Trans-Acting
- Trans Acting Factor
- Trans-Acting Factors
- Factors, Trans-Acting
- Trans Acting Factors
Nuclear Trans-Acting Factor- Nuclear Trans-Acting Factor
- Factor, Nuclear Trans-Acting
- Nuclear Trans Acting Factor
- Trans-Acting Factor, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Trans-Activators".
Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".
This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 | | 1993 | 1 | 0 | 1 | | 1994 | 2 | 0 | 2 | | 1995 | 3 | 1 | 4 | | 1996 | 8 | 2 | 10 | | 1997 | 3 | 0 | 3 | | 1998 | 11 | 2 | 13 | | 1999 | 18 | 2 | 20 | | 2000 | 18 | 2 | 20 | | 2001 | 15 | 5 | 20 | | 2002 | 24 | 8 | 32 | | 2003 | 13 | 5 | 18 | | 2004 | 19 | 15 | 34 | | 2005 | 19 | 8 | 27 | | 2006 | 5 | 6 | 11 | | 2007 | 8 | 6 | 14 | | 2008 | 6 | 6 | 12 | | 2009 | 11 | 4 | 15 | | 2010 | 14 | 4 | 18 | | 2011 | 2 | 6 | 8 | | 2012 | 8 | 2 | 10 | | 2013 | 11 | 5 | 16 | | 2014 | 6 | 5 | 11 | | 2015 | 4 | 2 | 6 | | 2016 | 4 | 1 | 5 | | 2017 | 1 | 3 | 4 | | 2018 | 3 | 3 | 6 | | 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Trans-Activators" by people in Profiles.
-
Wheeler HE, Ploch S, Barbeira AN, Bonazzola R, Andaleon A, Fotuhi Siahpirani A, Saha A, Battle A, Roy S, Im HK. Imputed gene associations identify replicable trans-acting genes enriched in transcription pathways and complex traits. Genet Epidemiol. 2019 09; 43(6):596-608.
-
Catela C, Correa E, Wen K, Aburas J, Croci L, Consalez GG, Kratsios P. An ancient role for collier/Olf/Ebf (COE)-type transcription factors in axial motor neuron development. Neural Dev. 2019 01 18; 14(1):2.
-
Chang JW, Montgomery JE, Lee G, Moellering RE. Chemoproteomic Profiling of Phosphoaspartate Modifications in Prokaryotes. Angew Chem Int Ed Engl. 2018 11 26; 57(48):15712-15716.
-
Liu Q, Onal P, Datta RR, Rogers JM, Schmidt-Ott U, Bulyk ML, Small S, Thornton JW. Ancient mechanisms for the evolution of the bicoid homeodomain's function in fly development. Elife. 2018 10 09; 7.
-
Manso BA, Zhang H, Mikkelson MG, Gwin KA, Secreto CR, Ding W, Parikh SA, Kay NE, Medina KL. Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients. Leukemia. 2019 03; 33(3):638-652.
-
Xu J, Vanderzalm PJ, Ludwig M, Su T, Tokamov SA, Fehon RG. Yorkie Functions at the Cell Cortex to Promote Myosin Activation in a Non-transcriptional Manner. Dev Cell. 2018 08 06; 46(3):271-284.e5.
-
Cheng JX, Chen L, Li Y, Cloe A, Yue M, Wei J, Watanabe KA, Shammo JM, Anastasi J, Shen QJ, Larson RA, He C, Le Beau MM, Vardiman JW. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018 03 21; 9(1):1163.
-
Xiao X, Guo P, Shiota C, Zhang T, Coudriet GM, Fischbach S, Prasadan K, Fusco J, Ramachandran S, Witkowski P, Piganelli JD, Gittes GK. Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes. Cell Stem Cell. 2018 01 04; 22(1):78-90.e4.
-
Barr KA, Martinez C, Moran JR, Kim AR, Ramos AF, Reinitz J. Synthetic enhancer design by in silico compensatory evolution reveals flexibility and constraint in cis-regulation. BMC Syst Biol. 2017 Nov 29; 11(1):116.
-
Kang HS, Kumar D, Liao G, Lichti-Kaiser K, Gerrish K, Liao XH, Refetoff S, Jothi R, Jetten AM. GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation. J Clin Invest. 2017 12 01; 127(12):4326-4337.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|